Thermo Fisher Scientific Inc. (TMO)
NYSE·Healthcare·Medical - Diagnostics & Research
$471.36
+0.71%
Mkt Cap $195.48B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 23, 2026 | $10.86B | $11.01B | +1.29% | $5.25 | $5.44 | +3.62% | — | — |
| Q1 2026 Jan 29, 2026 | $11.95B | $12.21B | +2.22% | $6.45 | $6.57 | +1.86% | — | — |
| Q4 2025 Oct 22, 2025 | $10.92B | $11.12B | +1.87% | $5.50 | $5.79 | +5.27% | — | — |
| Q3 2025 Jul 23, 2025 | $10.68B | $10.86B | +1.62% | $5.23 | $5.36 | +2.49% | — | — |
| Q2 2025 Apr 23, 2025 | $10.23B | $10.36B | +1.29% | $5.10 | $5.15 | +0.98% | — | — |
| Q1 2025 Jan 30, 2025 | $11.28B | $11.39B | +1.04% | $5.94 | $6.10 | +2.69% | — | — |
| Q4 2024 Oct 23, 2024 | $10.63B | $10.60B | -0.34% | $5.25 | $5.28 | +0.57% | — | — |
| Q3 2024 Jul 24, 2024 | $10.50B | $10.54B | +0.34% | $5.12 | $5.37 | +4.88% | — | — |
| Q2 2024 Apr 24, 2024 | $10.15B | $10.35B | +1.87% | $4.71 | $5.11 | +8.49% | — | — |
| Q1 2024 Jan 31, 2024 | $10.73B | $10.89B | +1.48% | $5.64 | $5.67 | +0.53% | — | — |
| Q4 2023 Oct 25, 2023 | $10.65B | $10.57B | -0.67% | $5.61 | $5.69 | +1.43% | — | — |
| Q3 2023 Jul 26, 2023 | $10.98B | $10.69B | -2.67% | $5.43 | $5.15 | -5.16% | — | — |
| Q2 2023 Apr 26, 2023 | $10.67B | $10.71B | +0.41% | $4.95 | $5.03 | +1.62% | — | — |
| Q1 2023 Feb 1, 2023 | $10.43B | $11.45B | +9.83% | $5.19 | $5.40 | +4.05% | — | — |
| Q4 2022 Oct 26, 2022 | $9.94B | $10.68B | +7.37% | $4.78 | $5.08 | +6.28% | — | — |
| Q3 2022 Jul 28, 2022 | $9.97B | $10.97B | +10.06% | $4.99 | $5.51 | +10.42% | — | — |
| Q2 2022 Apr 28, 2022 | $10.69B | $11.82B | +10.52% | $6.18 | $7.25 | +17.31% | — | — |
| Q1 2022 Feb 2, 2022 | $10.55B | $10.70B | +1.48% | $5.22 | $6.54 | +25.29% | — | — |
| Q4 2021 Oct 27, 2021 | $8.30B | $9.33B | +12.37% | $4.67 | $5.76 | +23.34% | — | — |
| Q3 2021 Jul 28, 2021 | $8.30B | $9.27B | +11.69% | $5.44 | $5.60 | +2.94% | — | — |